The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia

References

• Global Initiative for Chronic Obstructive Lung Disease [homepage on the Internet]Global strategy for diagnosis, management, and prevention of COPD [updated 2012] Available from: http://www.goldcopd.orgAccessed October 5, 2015
   Google Scholar
• SinganayamASchembriSChalmersJDPredictors of mortality in hospitalized adults with acute exacerbation of chronic obstructive pulmonary disease. A systematic review and meta-analysisAnn Am Thorac Soc2013102818923607835
   PubMedGoogle Scholar
• BrightlingCEBiomarkers that predict and guide therapy for exacerbations of chronic obstructive pulmonary diseaseAnn Am Thorac Soc201310SupplS214S21924313775
   PubMedGoogle Scholar
• TertemizKCKömüsNEllidokuzHSevinçCCımrınAHKronik obstrüktif akciğer hastalığında mortalite ve mortaliteyi etkileyen faktörler [Mortality and factors affecting mortality in chronic obstructive pulmonary disease]Tuberk Toraks2012602114122 Turkish22779931
   PubMedGoogle Scholar
• GunenHHacievliyagilSSKosarFFactors affecting survival of hospitalized patients with COPDEur Respir J200526223424116055870
   PubMed Web of Science ®Google Scholar
• GunayESarınç UlaşlıSNeutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective studyInflammation201437237483024078279
   PubMed Web of Science ®Google Scholar
• SivaRGrenRHBrightlingCEEosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trialEur Respir J200729590691317301099
   PubMed Web of Science ®Google Scholar
• BafadhelMDaviesLCalverleyPMAaronSDBrightlingCEPavordIDBlood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysisEur Respir J201444378979124925917
   PubMed Web of Science ®Google Scholar
• BafadhelMMcKennaSTerrySAcute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkersAm J Respir Crit Care Med2011184666267121680942
   PubMed Web of Science ®Google Scholar
• BafadhelMMcCormickMSahaSProfiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary diseaseRespiration2012831364421912093
   PubMed Web of Science ®Google Scholar
• BafadhelMMcKennaSTerrySBlood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trialAm J Respir Crit Care Med20121861485522447964
   PubMed Web of Science ®Google Scholar
• IliazSIliazROrtakoyluGBahadirABagciBACaglarEValue of neutrophil/lymphocyte ratio in the differential diagnosis of sarcoidosis and tuberculosisAnn Thorac Med20149423223525276243
   PubMed Web of Science ®Google Scholar
• UlasliSSOzyurekBAYilmazEBUlubayGMean platelet volume as an inflammatory marker in acute exacerbation of chronic obstructive pulmonary diseasePol Arch Med Wewn2012122628429022576316
   PubMed Web of Science ®Google Scholar
• WangRTLiJYCaoZGLiYMean platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary diseaseRespirology20131881244124823786593
   PubMed Web of Science ®Google Scholar
• CedrésSTorrejonDMartínezANeutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancerClin Transl Oncol2012141186486922855161
   PubMed Web of Science ®Google Scholar
• WalshSRCookEJGoulderFJustinTAKeelingNJNeutrophil-lymphocyte ratio as a prognostic factor in colorectal cancerJ Surg Oncol200591318118416118772
   PubMed Web of Science ®Google Scholar
• TamhaneUUAnejaSMontgomeryDRogersEKEagleKAGurmHSAssociation between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndromeAm J Cardiol2008102665365718773982
   PubMed Web of Science ®Google Scholar
• SahinFYazarEYıldızPProminent features of platelet count, plateletcrit, mean platelet volume and platelet distribution width in pulmonary tuberculosisMultidiscip Respir Med2012713823114411
   PubMed Web of Science ®Google Scholar
• KisacikBTufanAKalyoncuUMean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritisJoint Bone Spine200875329129418403245
   PubMed Web of Science ®Google Scholar
• LiuSJiananRHanGMean platelet volume: a controversial marker of disease activity in Crohn’s diseaseEur J Med Res2012172723058104
   PubMed Web of Science ®Google Scholar
• AnthonisenNRManfredaJWarrenCPHersfieldESHardingGKNelsonNAAntibiotic therapy in exacerbations of chronic obstructive pulmonary diseaseAnn Inter Med19871066196204
   PubMed Web of Science ®Google Scholar
• MirsaeidiMPeyraniPAlibertiSThrombocytopenia and thrombocytosis at time of hospitalization predict mortality in patients with community-acquired pneumoniaChest2010137241642019837825
   PubMed Web of Science ®Google Scholar
• SaettaMDi StefanoAMaestrelliPAirway eosinophilia in chronic bronchitis during exacerbationsAm J Respir Crit Care Med19941506 Pt 1164616527952628
   PubMed Web of Science ®Google Scholar
• BrightlingCEMonteiroWWardRSputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trialLancet200035692401480148511081531
   PubMed Web of Science ®Google Scholar
• HospersJJSchoutenJPWeissSTPostmaDSRijckenBEosinophilia is associated with increased all-cause mortality after a follow-up of 30 years in a general population sampleEpidemiology200011326126810784241
   PubMed Web of Science ®Google Scholar
• UlricCSFrederiksenJMortality and markers of risk of asthma death among 1,075 outpatients with asthmaChest1995108110157606941
   PubMed Web of Science ®Google Scholar
• SahaSBrightlingCEEosinophilic airway inflammation in COPDInt J Chron Obstruct Pulmon Dis200611394718046901
   PubMedGoogle Scholar
• HurstJRDonaldsonGCPereraWRUse of plasma biomarkers at exacerbation of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2006174886787416799074
   PubMed Web of Science ®Google Scholar
• ThomsenMIngebrigtsenTSMarottJLInflammatory biomarkers and exacerbations in chronic obstructive pulmonary diseaseJAMA2013309222353236123757083
   PubMed Web of Science ®Google Scholar
• Pinto-PlataVMMüllerovaHTosoJFC-reactive protein in patients with COPD, control smokers and non-smokersThorax2006611232816143583
   PubMed Web of Science ®Google Scholar
• Antonescu-TurcuALTomicRC-reactive protein and copeptin: Prognostic predictors in chronic obstructive pulmonary disease exacerbationsCurr Opin Pulm Med200915212012519532026
   PubMed Web of Science ®Google Scholar
• QuonBSGanWQSinDDContemporary management of acute exacerbations of COPD. A systematic review and metaanalysisChest2008133375676618321904
   PubMed Web of Science ®Google Scholar
• FordESHospital discharges, readmissions, and ED visits for COPD or bronchiectasis among US adults: findings from the nationwide inpatient sample. 2001–2012 and Nationwide Emergency Department Sample 2006–2011Chest2015147498999825375955
   PubMed Web of Science ®Google Scholar
• Garcia-AymerichJFarreroEFelezMARisk factors of readmission to hospital for a COPD exacerbation: a prospective studyThorax200358210010512554887
   PubMed Web of Science ®Google Scholar
• JingZChunCNingSSystemic inflammatory marker CRP was better predictor of readmission for AECOPD than sputum inflammatory markersArch Bronconeumol Epub2015520
   Web of Science ®Google Scholar
• ColetaKDSilveiraLVLimaDFRampinelliEAGodoyIGodoyIPredictors of first year survival in patients with advanced COPD treated using long-term oxygen therapyRespir Med2008102451251818191558
   PubMed Web of Science ®Google Scholar